Home / Mesothelioma Locations / Mesothelioma United States / Mesothelioma in West Virginia

Mesothelioma in West Virginia

While mesothelioma is a problem in all states, the specific incident rate for West Virginia is 1.5 / 100,000. This is above the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in WV, recent WV mesothelioma-related court cases, mesothelioma specialists in WV and potential asbestos hotspots in West Virginia.

[doptabs] [doptab title=”Overview”]

West Virginia Mesothelioma Info

By clicking on the above tabs, you will find information on mesothelioma specific to the state of West Virginia

West Virginia Research and Clinical Trials

This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.

West Virginia Doctors and Hospitals

This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.

West Virginia Cases

This is a partial list of relevant court cases on mesothelioma in your state.

Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.

[/doptab] [doptab title=”Treatment and Research”]

Clinical Trials

[dopaccordions] [dopaccordion title=”Active, not recruiting PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: vatalanib
More Information

[/dopaccordion] [dopaccordion title=”Active, not recruiting Sorafenib in Treating Patients With Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: sorafenib tosylate
More Information

[/dopaccordion] [dopaccordion title=”Recruiting An Efficacy Study of MORAb-009 in Subjects With Pleural Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Pleural Mesothelioma
Intervention: Drug: MORAb-009 by IV on Days 1 and 8 every 21 days for 6 cycles.
More Information

[/dopaccordion] [dopaccordion title=”Completed Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: erlotinib hydrochloride
More Information

[/dopaccordion] [dopaccordion title=”Active, not recruiting Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: carboplatin;   Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium
More Information

[/dopaccordion] [dopaccordion title=”Active, not recruiting AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: cediranib maleate
More Information

[/dopaccordion] [dopaccordion title=”Suspended Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: everolimus
More Information

[/dopaccordion] [dopaccordion title=”Completed Gefitinib in Treating Patients With Malignant Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: gefitinib
More Information

[/dopaccordion] [dopaccordion title=”Active, not recruiting Pazopanib in Treating Patients With Malignant Pleural Mesothelioma” icon=27 activeicon=28]

Condition: Malignant Mesothelioma
Intervention: Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis
More Information

[/dopaccordion] [dopaccordion title=”Recruiting Collecting Tumor Samples From Patients With Gynecological Tumors” icon=27 activeicon=28]

Condition: Cancer
Intervention: Other: biologic sample preservation procedure
More Information

[/dopaccordion] [/dopaccordions] [/doptab] [doptab title=”Doctors and Hospitals”]

Hospitals and Cancer Centers

We do not have any doctors or cancer centers for this state at the moment.

[/doptab] [doptab title=”Cases”]

Cases

Ratliff v. Norfolk S. Ry. Co.
No. 34156, SUPREME COURT OF APPEALS OF WEST VIRGINIA, February 4, 2009, Submitted, March 12, 2009, Filed

Adams v. Consol. Rail Corp.
No. 31271 , SUPREME COURT OF APPEALS OF WEST VIRGINIA, October 8, 2003, Submitted , December 4, 2003, Filed

Lamphere v. Consol. Rail Corp.
No. 29691, SUPREME COURT OF APPEALS OF WEST VIRGINIA, November 7, 2001, Submitted , November 30, 2001, Filed

State ex rel. Allman v. MacQueen
No. 29767, No. 29768, No. 29769, SUPREME COURT OF APPEALS OF WEST VIRGINIA, June 27, 2001, Submitted , July 6, 2001, Filed

[/doptab] [doptab title=”Lawyers”]

If you would like information on how to see the published ratings for different mesothelioma lawyers and law firms, please fill-in the form below: